Expression of E cadherin and Ki 67: Emerging Prognostic Markers in Triple-Negative Breast Cancer

Nair N, Shet T, Parma V, Havaldar R, Gupta S, Budrukkar A et al (2018) Breast cancer in a tertiary cancer centre in India – an audit, with outcome analysis. Indian J Cancer 55:16–22

National cancer registry program, Three year report of the PBCRs (2009–2011). Comparison of cancer incidence and patterns of all population based cancer registry. Published by NCDIR-NCRP (ICMR). Bangalore 562110. Available from: http// www.pbcrindia.org.chapter 2 leading sites of cancer, pg12–80. [Last accessed on 2017 Aug]

Nakagawa M, Bando Y, Nagao N, Morimoto M, Takai C, Ohnishi T et al (2011) Expression of p 53, Ki-67, E- cadherin, N- cadherin and TOP2A in triple-negative breast cancer. Anti Cancer Res 31:2389–2394

Ricciardi GR, Adamo B, Leni A, Licata L, Cardia R, Ferraro G et al. (2015) Androgen receptor (AR), E cadherin and Ki – 67 as emerging targets and novel prognostic markers in triple negative breast cancer (TNBC) patients. PLoS One 10(7):e0132647. https://doi.org/10.1371/Journal.pone.0132647

Keam B, Im SA, Lee KH, Han SW, Oh DY, Kim JH et al. (2011) Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. Breast Cancer Res 13R22

Peng Y, Butt YM, Chen B, Zang X (2017) Update on immunohistochemical analysis in breast lesions. Arch Pathol Lab Med 141:1033–1050

Tang D, Xu S, Zang Q, Zhao W (2012) The expression and clinical significance of the androgen receptor and E cadherin in triple negative breast cancer. Med Oncol 29:526–533

Kayahan M, Idiz UO, Gucin Z, Erozgen F, Memmi N, Muslumanoglu M et al (2014) Clinical significance of androgen receptor, CK-5/6, Ki-67 and molecular subtypes in breast cancer. J Breast Health 10:201–208

Pan Y, Yuan Y, Liu G, Wei Y P 53 and Ki -67 as prognostic markers in triple negative breast cancer patients. PLoS One 12(2):e0172324. https://doi.org/10.1371/journal.pone.0172324

Dowsett M, Neilson TO, A’Hem R, Bartlett J, Coombes RC, Cuzick J et al (2011) Assessment of Ki-67 in breast cancer: recommendations from the international Ki-67 in breast cancer working group. J Natl Cancer Inst 103:1656–1664